Friday, November 10, 2017 4:54:48 PM
I noted Sidney's letter to one of the shareholders and he strikes me as the type of owner and CEO that is not overly conerned with the OTC and their concerns, but first and foremost with patient care and completing the necessary steps to release and sell his product. The video opens with "patent pending" so I wonder where they are with that important benchmark.
Everything I have read, from product offering to FDA acceptance to market release status to share structure to SEC filing delinquency and commitment to meet complliance, and more importantly the man's own words - say to stick with these guys. Good things are forthcoming.
“Wo ein Wille ist, da ist auch ein Weg”
- Albert Einstein, Tokyo, 1922
Recent ALRTF News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/29/2023 12:53:49 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/28/2023 08:49:25 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/10/2023 09:15:16 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM